Western blot (WB): | 1:500-2000 |
Immunohistochemistry (IHC): | 1:50-400 |
Immunocytochemistry/Immunofluorescence (ICC/IF): | 1:50-400 |
(Boiling the paraffin sections in 10mM citrate buffer,pH6.0,or PH8.0 EDTA repair liquid for 20 mins is required for the staining of formalin/paraffin sections.) Optimal working dilutions must be determined by end user. |
Western blot analysis of CDK2 using anti-CDK2 antibody (PB9534). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human Jurkat whole cell lysates,
Lane 2: human HepG2 whole cell lysates,
Lane 3: human U2OS whole cell lysates,
Lane 4: human K562 whole cell lysates,
Lane 5: human T-47D whole cell lysates,
Lane 6: human Caco-2 whole cell lysates,
Lane 7: human 293T whole cell lysates,
Lane 8: human PC-3 whole cell lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with rabbit anti-CDK2 antigen affinity purified polyclonal antibody (PB9534) at a dilution of 1:1000 and probed with a goat anti-rabbit IgG-HRP secondary antibody (Catalog # BA1054). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for CDK2 at approximately 30 kDa. The expected band size for CDK2 is at 30,34 kDa.
IHC analysis of CDK2 using anti-CDK2 antibody (PB9534) .
CDK2 was detected in a paraffin-embedded section of human invasive urothelial carcinoma of the bladder with squamous differentiation tissue. The tissue section was incubated with rabbit anti-CDK2 Antibody (PB9534) at a dilution of 1:200 and developed using HRP Conjugated Rabbit IgG Super Vision Assay Kit (Catalog # SV0002) with DAB (Catalog # AR1027) as the chromogen.
IF analysis of CDK2 using anti-CDK2 antibody (PB9534) and anti-Beta Tubulin antibody (M01857-3).
CDK2 was detected in an immunocytochemical section of A549 cells. The section was incubated with rabbit anti-CDK2 Antibody (PB9534) at a dilution of 1:100. Dylight488-conjugated Anti-rabbit IgG Secondary Antibody (green)(Catalog#BA1127) and Dylight594-conjugated Anti-mouse IgG Secondary Antibody (red)(Catalog#BA1141) were used as secondary antibody.
Western blot analysis of CDK2 using anti-CDK2 antibody (PB9534). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human Jurkat whole cell lysates,
Lane 2: human HepG2 whole cell lysates,
Lane 3: human U2OS whole cell lysates,
Lane 4: human K562 whole cell lysates,
Lane 5: human T-47D whole cell lysates,
Lane 6: human Caco-2 whole cell lysates,
Lane 7: human 293T whole cell lysates,
Lane 8: human PC-3 whole cell lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with rabbit anti-CDK2 antigen affinity purified polyclonal antibody (PB9534) at a dilution of 1:1000 and probed with a goat anti-rabbit IgG-HRP secondary antibody (Catalog # BA1054). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for CDK2 at approximately 30 kDa. The expected band size for CDK2 is at 30,34 kDa.
IHC analysis of CDK2 using anti-CDK2 antibody (PB9534) .
CDK2 was detected in a paraffin-embedded section of human invasive urothelial carcinoma of the bladder with squamous differentiation tissue. The tissue section was incubated with rabbit anti-CDK2 Antibody (PB9534) at a dilution of 1:200 and developed using HRP Conjugated Rabbit IgG Super Vision Assay Kit (Catalog # SV0002) with DAB (Catalog # AR1027) as the chromogen.
IF analysis of CDK2 using anti-CDK2 antibody (PB9534) and anti-Beta Tubulin antibody (M01857-3).
CDK2 was detected in an immunocytochemical section of A549 cells. The section was incubated with rabbit anti-CDK2 Antibody (PB9534) at a dilution of 1:100. Dylight488-conjugated Anti-rabbit IgG Secondary Antibody (green)(Catalog#BA1127) and Dylight594-conjugated Anti-mouse IgG Secondary Antibody (red)(Catalog#BA1141) were used as secondary antibody.